BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19616529)

  • 21. High resolution melting for mutation scanning of TP53 exons 5-8.
    Krypuy M; Ahmed AA; Etemadmoghadam D; Hyland SJ; ; DeFazio A; Fox SB; Brenton JD; Bowtell DD; Dobrovic A
    BMC Cancer; 2007 Aug; 7():168. PubMed ID: 17764544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis.
    Takano EA; Mitchell G; Fox SB; Dobrovic A
    BMC Cancer; 2008 Feb; 8():59. PubMed ID: 18298804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High resolution melting analysis for mutation detection for PTPN11 gene: applications of this method for diagnosis of Noonan syndrome.
    Lo FS; Luo JD; Lee YJ; Shu SG; Kuo MT; Chiou CC
    Clin Chim Acta; 2009 Nov; 409(1-2):75-7. PubMed ID: 19737548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution DNA melting analysis: advancements and limitations.
    Wittwer CT
    Hum Mutat; 2009 Jun; 30(6):857-9. PubMed ID: 19479960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.
    Willems AJ; Dawson SJ; Samaratunga H; De Luca A; Antill YC; Hopper JL; Thorne HJ;
    Clin Cancer Res; 2008 May; 14(10):2953-61. PubMed ID: 18445692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles.
    Colosimo A; Guida V; De Luca A; Cappabianca MP; Bianco I; Palka G; Dallapiccola B
    Hum Mutat; 2002 Mar; 19(3):287-95. PubMed ID: 11857746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid detection of solute carrier family 4, member 1 (SLC4A1) mutations and polymorphisms by high-resolution melting analysis.
    Nettuwakul C; Sawasdee N; Yenchitsomanus PT
    Clin Biochem; 2010 Mar; 43(4-5):497-504. PubMed ID: 20035734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of specific BRCA1 and BRCA2 variants by DHPLC.
    Gross E; Arnold N; Pfeifer K; Bandick K; Kiechle M
    Hum Mutat; 2000 Oct; 16(4):345-53. PubMed ID: 11013445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
    James PA; Harris M; Lindeman GJ; Mitchell G
    J Med Genet; 2008 Nov; 45(11):765-6. PubMed ID: 18978334
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of DNA variations in the polymorphic hydroxymethylbilane synthase gene by high-resolution melting analysis.
    Ulbrichova-Douderova D; Martasek P
    Anal Biochem; 2009 Dec; 395(1):41-8. PubMed ID: 19664584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of high-resolution melting analysis for screening the LDL receptor gene.
    Laurie AD; George PM
    Clin Biochem; 2009 Apr; 42(6):528-35. PubMed ID: 19118540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New sequence variants in BRCA1 and BRCA2 genes detected by high-resolution melting analysis in an elderly healthy female population in Croatia.
    Cvok ML; Cretnik M; Musani V; Ozretic P; Levanat S
    Clin Chem Lab Med; 2008; 46(10):1376-83. PubMed ID: 18844490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penetrance of BRCA1/BRCA2 specific gene mutations in Iranian women with breast cancer.
    Hashemian AH; Hajizadeh E; Kazemnejad A; Atri M; Mehdipour P
    Saudi Med J; 2009 Jan; 30(1):41-4. PubMed ID: 19139771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation scanning using high-resolution melting.
    Taylor CF
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):433-7. PubMed ID: 19290876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.
    Maehle L; Apold J; Paulsen T; Hagen B; Løvslett K; Fiane B; Van Ghelue M; Clark N; Møller P
    Clin Cancer Res; 2008 Nov; 14(22):7569-73. PubMed ID: 19010876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutations.
    Liyanage KE; Hooper AJ; Defesche JC; Burnett JR; van Bockxmeer FM
    Ann Clin Biochem; 2008 Mar; 45(Pt 2):170-6. PubMed ID: 18325181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for the BRCA1-ins6kbEx13 mutation: potential for misdiagnosis. Mutation in brief #964. Online.
    Ramus SJ; Harrington PA; Pye C; Peock S; Cook MR; Cox MJ; Jacobs IJ; DiCioccio RA; Whittemore AS; Piver MS; EMBRACE ; Easton DF; Ponder BA; Pharoah PD; Gayther SA
    Hum Mutat; 2007 May; 28(5):525-6. PubMed ID: 17397054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a scoring system to screen for BRCA1/2 mutations.
    Evans GR; Lalloo F
    Methods Mol Biol; 2010; 653():237-47. PubMed ID: 20721747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced mismatch mutation analysis: simultaneous detection of point mutations and large scale rearrangements by capillary electrophoresis, application to BRCA1 and BRCA2.
    Houdayer C; Moncoutier V; Champ J; Weber J; Viovy JL; Stoppa-Lyonnet D
    Methods Mol Biol; 2010; 653():147-80. PubMed ID: 20721742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.